1xbetÍøÒ³°æ¶¡Ç¿¿ÎÌâ×éÓëҩѧԺÈÄŸú¿ÎÌâ×éºÏ×÷£¬ÔÚ10Ô·ݳö°æµÄ¡¶Antiviral Research¡·ÔÓÖ¾ÉÏ·¢±íÌâΪ¡°Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro¡±µÄÑо¿ÂÛÎÄ¡£¸ÃÂÛÎÄÆÀ¹ÀÁ˶àÖÖÐÂÐÍàŵͪÀ໯ºÏÎïÒÖÖÆ°£²©À²¡¶¾¸ÐȾµÄ¿¹²¡¶¾Ð§¹û£¬¼ø¶¨³öÁ½ÖÖ¸ßЧÒÖÖÆ°£²©À²¡¶¾¸ÐȾµÄÐÂÐÍ»¯ºÏÎ²¢½øÒ»²½½ÒʾÆäͨ¹ý×÷ÓÃÓÚ¡°à×ऴÓÍ·ºÏ³Éͨ·¡±ÖйؼüµÄ¶þÇâÈéÇåËáÍÑÇâøDHODH£¬·¢»Ó¿¹²¡¶¾¸ÐȾ»îÐÔ¡£¸ÃÑо¿³É¹û¶ÔÖÎÁÆ°£²©À²¡¶¾¸ÐȾ¾ßÓÐDZÔÚµÄÁÙ´²×ª»¯Ó¦ÓüÛÖµ¡£
з¢Í»·¢²¡¶¾ÐÔ´«È¾²¡ÑÏÖØÍþвȫÇò¹«¹²½¡¿µ£¬½ü¶þÊ®ÄêÀ´£¬³ÊÏÖ³öÓúÑÝÓúÁÒ£¬Óú·¢Óú¿ìµÄÇ÷ÊÆ¡£¿ª·¢¹ãÆס¢¸ßЧµÄ¿¹²¡¶¾Ò©ÎÊÇÓ¦¶Ôз¢Í»·¢²¡¶¾ÐÔ´«È¾²¡µÄÓÐÀûÎäÆ÷¡£°£²©À²¡¶¾ÊÇÒ»ÖÖµ¥¹É¸ºÁ´RNA²¡¶¾£¬ÓÐ×űÈйڲ¡¶¾¸ü¸ßµÄÖ²¡ÐÔºÍËÀÍöÂÊ£¨¸ß´ï50%£©£¬½ü¼¸ÄêÔÚ¸Õ¹û¡¢¼¸ÄÚÑǵȵضà´Î¾Ö²¿±¬·¢¡£ËäÈ»¶à·¢ÓÚÎ÷·ÇµØÇø£¬Æä¸ßÖ²¡ÐԺʹ«È¾ÐÔ¶ÔÈ«Çò¹«¹²½¡¿µÈÔÊÇÒ»ÖÖÖØ´óÍþв¡£ÈðµÂÎ÷ΤÊÇÒ»ÖÖÖ±½Ó°ÐÏò²¡¶¾¾ÛºÏøµÄºËÜÕÀàËÆÎ¾ßÓнϺõĿ¹²¡¶¾Ð§¹û¡£È»¶ø£¬ÓÐÑо¿±íÃ÷²¡¶¾µÄ²»¶ÏÍ»±ä»áµ¼Ö²¡¶¾¶Ô¸ÃÒ©Îï²úÉúÄÍÊÜ[1]£¬Òò´Ë¿ª·¢ÓÐЧµÄ¿¹°£²©À²¡¶¾¸ÐȾҩÎïÆÈÔÚü½Þ¡£Ö±½Ó°ÐÏò²¡¶¾µÄÒ©ÎïµÈ¿ÉÄܵ¼ÖÂÄÍÒ©ÖêµÄ²úÉú£¬¶ø×÷ÓÃÓÚϸ°ûËÞÖ÷µÄÒ©ÎïÔò¿ÉÒԺܴó³Ì¶ÈÉϱÜÃâÄÍÒ©ÖêµÄ³öÏÖ¡£
°£²©À²¡¶¾µÄÅàÑøÐèÔÚÉúÎﰲȫ4¼¶£¨BSL-4£©ÊµÑéÊÒÄÚ½øÐУ¬Òò´Ë´ó´ó½µµÍÁËɸѡ¿¹²¡¶¾Ò©ÎïµÄЧÂÊ¡£Ñо¿ÍŶÓÊ×ÏȽ¨Á¢ÁË°²È«¿É¿¿£¬ÇÒÄ£Äâ°£²©À²¡¶¾¸´ÖƵÄϸ°ûÄ£ÐÍ[2]£¬¶ÔһϵÁÐÐÂÐ͵ÄàŵͪÀ໯ºÏÎïµÄ¿¹²¡¶¾»îÐÔ½øÐÐɸѡ£¬½á¹û±íÃ÷RYL-687¡¢RYL-686ºÍRYL-681»¯ºÏÎïÒÖÖƲ¡¶¾¸ÐȾµÄIC50£¨°ëÒÖÖƲ¡¶¾Å¨¶È£©¾ù±ÈÈðµÂÎ÷ΤµÍ£¬²¢ÇÒϸ°û¶¾ÐԷdz£µÍ(ͼ1)¡£
ͼ1.¿¹²¡¶¾Ð§Á¦IC50ºÍϸ°û¶¾ÐÔCC50ÆÀ¹À¡£
|
Ëæºó£¬Ñо¿ÍŶӶÔÓÐЧ»¯ºÏÎïµÄ×÷Óðеã½øÐÐÁ˼ø¶¨£¨Í¼2£©¡£Ö®Ç°Ñо¿±íÃ÷àŵͪÀ໯ºÏÎï¿ÉÒԺ͡°à×ऴÓÍ·ºÏ³Éͨ·¡±µÄ¶þÇâÈéËáÍÑÇâøDHODHÓÐÏ໥×÷ÓÃ[3]¡£×÷Õßͨ¹ýÍâÔ´²¹¸ø ¡°à×ऴÓÍ·ºÏ³Éͨ·¡±ÉÏÏÂÓεĴúл²úÎïÒÔ¼°ÌåÍâø»îʵÑ飬֤Ã÷àŵͪÀ໯ºÏÎïͨ¹ý°ÐÏòDHODH·¢»Ó¿¹²¡¶¾¹¦ÄÜ¡£ÁíÍ⣬DHODH»¹±»±¨µÀ¿É×÷Ϊйڲ¡¶¾µÄÒ©Îï°Ðµã[4]£¬Ìáʾ¸Ã°ÐµãµÄ¹ãÆ׿¹²¡¶¾×÷Óá£
ͼ2.×÷ÓðеãÓëà×ऺϳÉͨ·ʾÒâͼ¡£ |
×îºó£¬Í¨¹ýÓëÖйú¿ÆѧԺÎ人¹ú¼ÒÉúÎﰲȫʵÑéÊÒºÏ×÷£¬ÀûÓ𣲩À»î²¡¶¾£¬ÔÚϸ°ûˮƽÉϲâÊÔÁËÉÏÊöÈýÖÖ»¯ºÏÎïµÄ¿¹²¡¶¾Ð§¹û¡£»¯ºÏÎïÔڻ¶¾¸ÐȾµÄϸ°ûÄ£ÐÍÉÏ, ÒÀȻչÏÖ³ö±ÈÈðµÂÎ÷Τ¸üµÍµÄIC50Öµ£¨Í¼3£©£¬½øÒ»²½Ö¤Ã÷ÁËÒÔÉÏ»¯ºÏÎï¸ßЧµÄ¿¹°£²©À²¡¶¾¸ÐȾ»îÐÔ¡£
ͼ3.Ò°Éú°£²©À²¡¶¾ÒÖÖÆЧÂÊÆÀ¹À¡£
|
1xbetÍøÒ³°æ¶¡Ç¿Ñо¿Ô±¡¢Ò©Ñ§ÔºÈÄŸúÑо¿Ô±Îª¸ÃÂÛÎĵĹ²Í¬Í¨Ñ¶×÷Õߣ¬1xbetÍøÒ³°æ²©Ê¿Éú¹¨Ã÷Àö¡¢Ò©Ñ§ÔºÑîÒãÇ첩ʿΪ¹²Í¬µÚÒ»×÷Õߣ¬Î人¹ú¼Ò°²È«ÊµÑéÊÒ»Æß®ºÍÎ人²¡¶¾ËùµË·ÆÑо¿Ô±Îª»î²¡¶¾Ñо¿ÌṩÖØÒªÖ§³Ö£»ÉϺ£°Í˹µÂËùÖÓ¾¢ÊµÑéÊÒ¸ÊÌìÓ÷¡¢Ò©Ñ§ÔºÈÄŸúʵÑéÊÒÎâÔ½ºÍ¸ßºìÓ¢¡¢ÖмìÔºÍõÓÓ´ºÊµÑéÊÒÑîٻٻ¡¢Äô½¨»Ô¡¢ºÍ»Æά½ðÒÔ¼°¸´µ©´óѧÕÅÈÙÒàΪ±¾Ñо¿×ö³öÖØÒª¹±Ïס£
±¾Ñо¿ÓÉÖйú¿ÆѧԺÎ人ÉúÎﰲȫ¹ú¼ÒʵÑéÊÒÏȽø¿Í»§ÅàÓýÏîÄ¿ £¨2021ACCP-MS03£©£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð (32041005£¬81773567)£¬±±¾©ÊÐ×ÔÈ»¿Æѧ»ù½ð£¨M21001£©ÒÔ¼°Ç廪´óѧÈ˲ÅÒý½øÆô¶¯¾·Ñ£¨53332101319£©µÈÏîÄ¿¾·ÑµÄÖ§³ÖÏÂÍê³É¡£
²Î¿¼ÎÄÏ×£º
1. Lo, M.K., et al., Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases. Proc Natl Acad Sci U S A, 2020. 117(43): p. 26946-26954.
2. Halfmann, P., et al., Generation of biologically contained Ebola viruses. Proc Natl Acad Sci U S A, 2008. 105(4): p. 1129-33.
3. Yang, Y., et al., Discovery, Optimization, and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors. J Med Chem, 2019. 62(8): p. 4056-4073.
4. Xiong, R., et al., Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein Cell, 2020. 11(10): p. 723-739.
